You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Frontiers in Cardiovascular Drug Discovery is an eBook series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships of molecules used in cardiovascular therapy. The eBook series should prove to be of great interest to all medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology. The fourth volume of the series covers the following topics: -Aspirin administration -Adenosine receptor targeting for cardiovascular therapy -Drug treatment of patients with coronary stenting -Immunosuppressive drugs in heart transplantation -PCSK9 inhibition for lowering LDL-C levels.
"Incidence of cancer is increasing all over the world and personalized therapies have become the trend in cancer therapy. Multidisciplinary approaches provide successful results for personalized therapies. As a part of a multidisciplinary healthcare team, oncology pharmacists (OPs) contribute to the rational use of chemotherapy by providing individual pharmaceutical care for cancer patients. A multidisciplinary approach is crucial for the success of cancer therapy. Pharmacists acting as a counsellor for medication-related issues in the multidisciplinary team have a vital role in the oncology setting. OPs are the clinical pharmacists specialized in oncology and they are involved in planning and implementation of pharmaceutical care. Additionally, OPs play an important role in providing comprehensive medication management and related care for cancer patients. We hope that this book will contribute to pharmacists' knowledge and practice in cancer management by provision of a clinical pharmacist's perspective"--
Proceedings of the 42nd OHOLO Conference held in Eilat, Israel, May 3-7, 1998
Throughout their life, plants interact with all sorts of microbes. Some of these are detrimental and cause disease; some interactions are mutually beneficial for both partners. It is clear that most, if not all, of the interactions are regulated by highly complex checks and balances sustained by signalling and exchange of messengers and nutrients. The interactions where both partners are alive for a significant part of their time together are called biotrophic. In this e-book we bring together 33 articles representing the current state-of-the-art in research about diverse biotrophic plant-microbe associations aimed at describing and understanding how these complex and ubiquitous partnerships work and ultimately support much of the land-based biosphere.
None
None